eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
2/2022
vol. 24
 
Share:
Send email
Share:
Original paper

Attitudes of family medicine residents in Ankara towards COVID-19 vaccines administered in Turkey: a descriptive, cross-sectional study

Hüsna Sarıca Çevik
1
,
Rana Baykan
2
,
Ayşe Gülsen Ceyhun Peker
2
,
Selda Tekiner
2

  1. Çankaya District Health Directorate, Ankara, Turkey
  2. Family Medicine Department, Ankara University Medical School, Ankara, Turkey
Family Medicine & Primary Care Review 2022; 24(2): 156–161
DOI: https://doi.org/10.5114/fmpcr.2022.115871
Online publish date: 2022/06/30
Article file
- 11 FM&PCR 2 22 - O - Sarica Cevik - Attitudes of family medicine - 1116.pdf  [0.52 MB]
Get citation
 
PlumX metrics:
 
1. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11 March 2020 [cited 18.06.2021]. Available from URL: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
2. T.C.S.B. Covid-19 As Bilgilendirme Platformu 2021 [cited 14.11.2021]. Available from URL: https://covid19asi.saglik.gov.tr/.
3. European Academy of Teachers in General Practice (Network within WONCA Europe). The European definition of general practice/family medicine. Available from URL: https://www.woncaeurope.org/file/3b13bee8-5891-455e-a4cb-a670d7bfdca2/Definition%20EURACTshort%20version%20revised%202011.pdf.
4. WHO. Infodemic 2020 [cited 20.06.2021]. Available from URL: https://www.who.int/health-topics/infodemic#tab=tab_1.
5. American Medical Association. Physician COVID-19 Vaccination Study (Final Report). EISAMR 2021 June [cited 4.01.2022]. Available from URL: https://www.ama-assn.org/system/files/2021-06/physician-vaccination-study-topline-report.pdf.
6. Eniola K, Sykes J. Four reasons for COVID-19 vaccine hesitancy among health care workers, and ways to counter them. Quick Tips, A Blog from FPM Journal 27 April 2021 [cited 4.01.2022]. Available from URL: https://www.aafp.org/journals/fpm/blogs/inpractice/entry/countering_vaccine_hesitancy.html.
7. Tagliamento M, Agostinetto E, Bruzzone M, et al. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2021; 103365.
8. Monin L, Laing AG, Muńoz-Ruiz M, et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol 2021; 22(6): 765–778.
9. WHO. Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac: interim guidance, 24 May 2021. Available from URL: https://apps.who.int/iris/handle/10665/341454.
10. Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 2021; 21(2): 181–192.
11. Geisen UM, Berner DK, Tran F, et al. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann Rheum Dis 2021; 80: 1306–1311.
12. Perl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2 – Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women. JAMA 2021; 325(19): 2013–2014, doi: 10.1001/jama.2021.5782.
13. CDC. COVID-19 Vaccines While Pregnant or Breastfeeding 2021 [cited 18.06.2021]. Available from URL: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html.
14. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med 2021; 385: 1535–1536.
15. Yin F, Wu Z, Xia X, et al. Unfolding the determinants of COVID-19 vaccine acceptance in China. J Med Internet Res 2021; 23(1): e26089.
16. Chirumbolo S. Vaccination hesitancy and the “myth” on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria? J Med Virol 2021; 93(7): 4049–4053.
17. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383(27): 2603–2615.
18. Jara A, Undurraga EA, González C, et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Engl J Med 2021; 385: 875–884.
19. Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med 2021; 27(2): 205–211.
20. Tanriover MD, Doanay HL, Akova M, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet 2021; 17; 398(10296): 213–222.
21. FDA. Emergency use authorization (EUA) of the Pfizer-Biontech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 12 years age and older. Silver Spring (MS): Food and Drug Administration; 2019.
22. Shaw RH, Stuart A, Greenland M, et al. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. Lancet 2021; 397(10289): 2043–2046.
23. Taquet M, Husain M, Geddes JR, et al. Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine. EClinicalMedicine 2021; 39: 101061.
24. Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021; 384(22): 2092–2101.
25. MacNeil JR, Su JR, Broder KR, et al. Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients, United States, April 2021. MMWR 2021; 70(17): 651–656.
26. Furer V, Eviatar T, Zisman D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 2021; 80: 1330–1338.
27. Yamur H. Aile Hekimlii asistanlarnn COVID-19 pandemisi döneminde influena, pnömokok ve COVID-19 alar hakknda bilgi, tutum ve davranlarnn deerlendirilmesi [dissertation]. Ankara: University of Health Sciences Ankara Health Application and Research Center; 2021.
28. Di Gennaro F, Murri R, Segala FV, et al. Attitudes towards Anti-SARS-CoV2 vaccination among healthcare workers: Results from a national survey in Italy. Viruses 2021; 13(3): 371.
29. Civelek B, Yazici O, Ozdemir N, et al. Attitudes of physicians towards COVID-19 vaccines and reasons of vaccine hesitancy in Turkey. Int J Clin 2021: e14399.
30. Wang J, Jing R, Lai X, et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines 2020; 8(3): 482.
31. Kaplan AK, Sahin MK, Parildar H, et al. The willingness to accept the COVID-19 vaccine and affecting factors among healthcare professionals: a cross-sectional study in Turkey. Int J Clin 2021; e14226.
32. Adal T, Koyuncu Y, Türkylmaz AS. Surveys in Covid-19 and Post Covid-19 Days. Ankara: Hacettepe University Institute of Population Studies and the United Nations Population Fund Turkey Country Office, 2021 [cited 14.11.2021] Available from URL: https://turkey.unfpa.org/en/publications/surveys-covid-19-and-post-covid-19-days.
Copyright: © 2022 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.